{"nct_id":"NCT00790036","title":"Phase III Study of RAD001 Adjuvant Therapy in Poor Risk Patients With Diffuse Large B-Cell Lymphoma (DLBCL) of RAD001 Versus Matching Placebo After Patients Have Achieved Complete Response With First-line Rituximab-chemotherapy","status":"COMPLETED","status_verified_date":"2017-06","start_date":"2009-07-24","start_date_type":"ACTUAL","primary_completion_date":"2016-06-15","primary_completion_date_type":"ACTUAL","completion_date":"2016-06-15","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}